Insider Transactions in Q4 2020 at Edesa Biotech, Inc. (EDSA)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 09
2020
|
Lorin K Johnson |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
4,262
+25.0%
|
$17,048
$4.0 P/Share
|
|
Nov 06
2020
|
Paul William Pay |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
1,218
+25.0%
|
$4,872
$4.0 P/Share
|
|
Nov 06
2020
|
Kathi Niffenegger Chief Financial Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
609
+25.0%
|
$2,436
$4.0 P/Share
|
|
Nov 06
2020
|
Michael J Brooks President |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
914
+14.85%
|
$3,656
$4.0 P/Share
|
|
Nov 05
2020
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
4,628
+0.22%
|
$18,512
$4.0 P/Share
|
|
Nov 05
2020
|
Carlo Sistilli |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
1,218
+25.0%
|
$4,872
$4.0 P/Share
|
|
Nov 02
2020
|
Velden Peter Van Der > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
70,314
+3.28%
|
$281,256
$4.0 P/Share
|
|
Oct 06
2020
|
Frank R. Oakes |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
609
+25.0%
|
$2,436
$4.0 P/Share
|